Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 12Terminated 9Withdrawn 4Recruiting 4Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Colorectal Neoplasms 8Breast Neoplasms 8Esophageal Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Carcinoma, Hepatocellular 6Glioblastoma 5Brain Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Colonic Neoplasms 4Cholangiocarcinoma 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Lymphatic Metastasis 3Glioma 3Endometrial Neoplasms 3Disease 3Astrocytoma 3Thyroid Neoplasms 2Recurrence 2Pain, Postoperative 2Oropharyngeal Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gliosarcoma 2Gastrointestinal Stromal Tumors 2

Interventions

Gemcitabine 77Fluorouracil 27Oxaliplatin 23130-nm albumin-bound paclitaxel 23Leucovorin 17Capecitabine 15Albumin-Bound Paclitaxel 15S 1 (combination) 14Taxes 11Irinotecan 10pembrolizumab 9folfirinox 9Radiosurgery 9Radiotherapy 7Drug Therapy 7irinotecan sucrosofate 6Cisplatin 6Pancreaticoduodenectomy 5Paclitaxel 5Injections 5Docetaxel 5Blood Specimen Collection 5apatinib 4Radiofrequency Ablation 4Radiation 4Biopsy 4tislelizumab 3rubitecan 3camrelizumab 3Stents 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pancreatic Neoplasms × Surgical Procedures, Operative × Clear all
NCT01591733 2021-05-28

FOLFIRINOX + RT for Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Unknown
48 enrolled 16 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡